UK proposes crypto lending tax changes
The UK government has proposed new tax rules that would change how cryptocurrency lending and liquidity pool transactions are taxed.
Liezl Gambe
Finance JournalistFinance journalist at Grafa with years of experience covering Asia-Pacific financial markets at S&P Global, Mortgage Ezy, and GMA Network.
Contact
Contact editorial teamArticles by Liezl Gambe
Dragonfly warns AI could boost crypto hacks
Dragonfly warned artificial intelligence could make crypto hacks faster, cheaper and more effective.
Energy
Vulcan Energy secures initial cash for flagship project
Vulcan Energy (ASX:VUL) has met its first strategic drawdown conditions to receive initial equity funds for its €2.2 billion Lionheart Project.
Cryptocurrency
Hyperliquid urges clear US crypto rules
Hyperliquid (CRYPTO:HYPE) asked the US Securities and Exchange Commission's Crypto Task Force to create clear rules for decentralised finance and blockchain protocols.
Orezone Gold reports 58,566 ounces of gold in Q2
Orezone Gold (ASX:ORE) increased its consolidated gold production to 58,566 ounces in the second quarter of 2026.
Financial
KPMG Australia prepares to cut hundreds of jobs
KPMG's (ASX:KPMG) Australia division plans to cut 200 to 1,000 staff roles and reduce partner distributions by up to 20%.
Technology
Nvidia H200 approvals expand to three Chinese firms
Three Chinese firms received U.S. approval to purchase advanced AI chips from Nvidia (NASDAQ:NVDA) and Advanced Micro Devices (NASDAQ:AMD), expanding the licensed customer group.
Energy
Ranger Energy Services expands ECHO rig fleet with Hess Corporation contract
Ranger Energy Services (NYSE:RNGR) announced a new agreement to provide three additional ECHO hybrid workover rigs to Hess Corporation (a subsidiary of Chevron (NYSE:CVX)), marking a continued expansion of its electrified rig fleet.
Summit Therapeutics signs $105 million Biossil agreement
Summit Therapeutics (NASDAQ:SMMT) sold its investigational Phase III precision antibiotic ridinilazole to Biossil for up to $105 million.
Spero signs $1.1 billion SP001 licensing deal
Spero Therapeutics (NASDAQ:SPRO) licensed SP001 from Innovent Biologics in an agreement valued at approximately US$1.1 billion.